Atlas Trials

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

Clinical trial NCT01969123 · TERMINATED

Trial details

NCT number
NCT01969123
Sponsor
FORUM Pharmaceuticals Inc
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Alzheimer's DiseaseDementia
Start date
2013-10-01
Primary completion
2017-01-01
Enrollment
474

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.